The case for aflatoxins in the causal chain of gallbladder cancer
Claudia Foerster1, Jill Koshiolc, Ariel R. Guerrero, Marcelo J. Kogan, Catterina Ferreccio2
Gastric Cancer: Nanoparticles as Tools to Improve Treatment Efficacy
Ariel R. Guerrero1, Felipe Oyarzun-Ampuero, Natalia Hassan, Alejandro H. Corvalán, Andrew F.G. Quest and Marcelo J. Kogan
miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway.
Riquelme I1, Tapia O, Leal P, Sandoval A, Varga MG, Letelier P, Buchegger K, Bizama C, Espinoza JA, Peek RM, Araya JC, Roa JC2.
BAG3 regulates total MAP1LC3B protein levels through a translational but not transcriptional mechanism.
Rodríguez AE1, López-Crisosto C, Peña-Oyarzún D, Salas D, Parra V, Quiroga C, Morawe T, Chiong M, Behl C, Lavandero S2.
HERPUD1 protects against oxidative stress-induced apoptosis through downregulation of the inositol 1,4,5-trisphosphate receptor.
Paredes F1, Parra V, Torrealba N, Navarro-Marquez M, Gatica D, Bravo-Sagua R, Troncoso R, Pennanen C, Quiroga C, Chiong M, Caesar C, Taylor WR, Molgó J, San Martin A, Jaimovich E, Lavandero S2.
New Molecular Insights of Insulin in Diabetic Cardiomyopathy
Westermeier F1, Riquelme J, Pavez M , Garrido V, Díaz A, Verdejo H, Castro PF ,García L and Lavandero S2.
